Novo Nordisk said that its weight-loss drug Wegovy has reached 1.2 million U.S. patients, with 55 million individuals covered by insurance.
Novo Nordisk Opposes ‘Government Price Setting’ As Elon Musk’s DOGE Gains Access To CMS Amid Bernie Sanders’ Criticism
